Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Adial Pharmaceuticals Inc before investing.

In this article, we go over a few key elements for understanding Adial Pharmaceuticals Inc’s stock price such as:

• Adial Pharmaceuticals Inc’s current stock price and volume
• Why Adial Pharmaceuticals Inc’s stock price changed recently
• Upgrades and downgrades for ADIL from analysts
• ADIL’s stock price momentum as measured by its relative strength

About Adial Pharmaceuticals Inc (ADIL)

Before we jump into Adial Pharmaceuticals Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Adial Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. The Company’s drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder (AUD). AD04 is used for the treatment of AUD in subjects with certain target genotypes, which were identified using its companion diagnostic genetic test. AD04 is a genetically targeted, serotonin-3 receptor antagonist, a therapeutic agent for the treatment of AUD. The Company’s AD04 also has the potential to treat other addictive disorders such as opioid use disorder, gambling, and obesity. The Company is also developing adenosine analogs for the treatment of pain and other disorders.

Want to learn more about Adial Pharmaceuticals Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Adial Pharmaceuticals Inc.

Adial Pharmaceuticals Inc’s Stock Price as of Market Close

As of February 28, 2024, 4:00 PM, CST, Adial Pharmaceuticals Inc’s stock price was $1.62.

Adial Pharmaceuticals Inc is up 85.5% from its previous closing price of $0.87.

During the last market session, Adial Pharmaceuticals Inc’s stock traded between $0.80 and $0.87. Currently, there are 1.18 million shares of Adial Pharmaceuticals Inc stock available for purchase.

Unfortunately, Adial Pharmaceuticals Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Adial Pharmaceuticals Inc Stock Price History

Adial Pharmaceuticals Inc’s (ADIL) price is currently up 42.11% so far this month.

During the month of February, Adial Pharmaceuticals Inc’s stock price has reached a high of $2.87 and a low of $0.77.

Over the last year, Adial Pharmaceuticals Inc has hit prices as high as $15.00 and as low as $0.77. Year to date, Adial Pharmaceuticals Inc’s stock is down 69.86%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Adial Pharmaceuticals Inc Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of February 27, 2024,, no analysts have changed their rating of Adial Pharmaceuticals Inc’s stock over the last month.

Additionally, you'll want to evaluate Adial Pharmaceuticals Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Adial Pharmaceuticals Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Adial Pharmaceuticals Inc (ADIL) by visiting AAII Stock Evaluator.

Relative Price Strength of Adial Pharmaceuticals Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of February 27, 2024, Adial Pharmaceuticals Inc has a weighted four-quarter relative price strength of -51.99%, which translates to a Momentum Score of 3 and is considered to be Very Weak.

Want to learn more about how Adial Pharmaceuticals Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Adial Pharmaceuticals Inc Stock Price: Bottom Line

As of February 28, 2024, Adial Pharmaceuticals Inc’s stock price is $1.62, which is up 85.5% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Adial Pharmaceuticals Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.